Levosimendan Can Improve the Level of B-Type Natriuretic Peptide and the Left Ventricular Ejection Fraction of Patients with Advanced Heart Failure: A Meta-analysis of Randomized Controlled Trials

ConclusionOur meta-analysis suggests that intravenous levosimendan can reduce BNP level and increase LVEF in patients with advanced heart failure to reduce the mortality at the shortest follow-up available.

http://link.springer.com/10.1007/s40256-020-00416-y

Source: American Journal of Cardiovascular Drugs - May 27, 2020 Category: Cardiology Source Type: research